Literature DB >> 17979652

ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions.

Anna Maria Calcagno1, In-Wha Kim, Chung-Pu Wu, Suneet Shukla, Suresh V Ambudkar.   

Abstract

ABC transporters play an important role in mediating the cytoplasmic concentration of endogenous and xenobiotic substances. They therefore influence the pharmacokinetic profile of a variety of drugs. By virtue of their localization to plasma membranes in the intestine, liver, blood-brain and other vital biological barriers, a majority of ABC drug transporters cause drug-drug interactions, decreased drug efficacy and multidrug resistance for chemotherapeutic agents. Thus, elucidating which drug entities are substrates for ABC drug transporters is a crucial step in the drug development and treatment process. Here, we review the current status of methodology used to categorize drug compounds as substrates or modulators for the major ABC drug transporters including ABCB1, ABCC1 and ABCG2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979652     DOI: 10.2174/156720107782151241

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  23 in total

Review 1.  Collateral sensitivity as a strategy against cancer multidrug resistance.

Authors:  Kristen M Pluchino; Matthew D Hall; Andrew S Goldsborough; Richard Callaghan; Michael M Gottesman
Journal:  Drug Resist Updat       Date:  2012-04-06       Impact factor: 18.500

Review 2.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

Authors:  Young Hee Choi; Ai-Ming Yu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.

Authors:  Miles A Miller; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2016-06-04       Impact factor: 15.470

Review 4.  Starvation, detoxification, and multidrug resistance in cancer therapy.

Authors:  Changhan Lee; Lizzia Raffaghello; Valter D Longo
Journal:  Drug Resist Updat       Date:  2012-03-04       Impact factor: 18.500

5.  The imaging probe development center and the production of molecular imaging probes.

Authors:  Gary L Griffiths
Journal:  Curr Chem Genomics       Date:  2008-06-13

Review 6.  Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications.

Authors:  P Kannan; C John; S S Zoghbi; C Halldin; M M Gottesman; R B Innis; M D Hall
Journal:  Clin Pharmacol Ther       Date:  2009-07-22       Impact factor: 6.875

7.  Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.

Authors:  Chirayu Patel; Leif Stenke; Sudhir Varma; Marita Lagergren Lindberg; Magnus Björkholm; Jan Sjöberg; Kristina Viktorsson; Rolf Lewensohn; Ola Landgren; Michael M Gottesman; Jean-Pierre Gillet
Journal:  Cancer       Date:  2013-05-14       Impact factor: 6.860

8.  Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.

Authors:  J Jacob Strouse; Irena Ivnitski-Steele; Anna Waller; Susan M Young; Dominique Perez; Annette M Evangelisti; Oleg Ursu; Cristian G Bologa; Mark B Carter; Virginia M Salas; George Tegos; Richard S Larson; Tudor I Oprea; Bruce S Edwards; Larry A Sklar
Journal:  Anal Biochem       Date:  2013-03-05       Impact factor: 3.365

9.  Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporter.

Authors:  Kentaro Takada; Nobutaka Imamura; Kirk R Gustafson; Curtis J Henrich
Journal:  Bioorg Med Chem Lett       Date:  2010-01-11       Impact factor: 2.823

10.  Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cells.

Authors:  Hongwei Zhang; Serguei V Vinogradov
Journal:  J Control Release       Date:  2010-01-20       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.